CHICAGO--(BUSINESS WIRE)--Gene delivery technologies are turning into the next big-ticket item globally, as the most recent investment received by VectorBuilder Inc., a global leader in this field, ...
New Rochelle, NY, August 13, 2018--A new study has shown that a single injection of a novel adeno-associated vector (AAV)-based therapy can result in improved enzyme activ-ity and glycogen clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback